Fact Based List:
Four Major Regulatory Changes to Digital Health Driving New Opportunities for Pharma
Submitted by Anonymous on Tue, 04/16/2019 - 16:00
- Digital Health Precertification: companies with high degrees of regulatory quality are eligible for shorter reviews and ONC certification
- Multiple Function Devices: The FDA will treat as separate the various functions of a digital health device, making it easier to have full-function products
- Companion Applications: The FDA will allow digital apps intended to supplement prescription drugs to be regulated as labeling and not require approval
- OTC Drug Digital Labeling: OTC drugs drugs may be approved based on evidence that consumers can use digital labeling to select a drug for treatment
Source: PWC
Source URL: https://www.pwc.com/us/acceleration-by-regulation?WT.mc_id=C...
List Ratings: |
Lists You Might Also Be Interested In
- Managed Healthcare Executive: Eight Trends Expected to Shape Managed Care Pharmacy in 2020
- Retained Annual Revenue Across US Pharmaceutical Sectors
- Top Ten Countries with Highest Total Expenditure on Pharmaceuticals (% total expenditure on health)
- PharmExec's Top Ten Pharma Companies 2019
- USA Today: 5 reasons why Target sold pharmacy biz to CVS
Login or register to post comments